Understand MSC expansion, quality checks and EHL banking before reviewing an individual plan.
Quick answer
Cultured cells are expanded under controlled conditions; not everything marketed as stem cell is a cultured MSC product. Ask about source, identity, culture method and release quality. EHL Bio publishes information about isolation, culture and storage. Khun Kim can coordinate a physician explanation of the proposal for your specific goal.
Isolation and expansion are separate steps. A freshly isolated fraction may contain multiple cell types, while expansion requires controlled processing and identity checks. Compare actual products, not simply the words fresh and cultured.
An advertised count does not establish viability, purity, sterility or benefit. Ask the physician why a dose and route were chosen and ask the laboratory about release checks. More cells do not automatically mean better outcomes.
EHL describes adipose-cell isolation and culture plus liquid-nitrogen banking. Ask which source your plan uses, whether harvesting is needed, the actual preparation schedule and any storage fees or future-use conditions.
A lecture photograph illustrates a topic. Expansion or post-thaw viability data are not patient outcomes. Ask for evidence for the specific product and indication and discuss relevance with the clinician. This article does not assign an unverified survival rate or treatment-success percentage.
Where harvesting and expansion are required, confirm scheduling before flights rather than assuming same-day completion. Khun Kim can coordinate consultation and appointments; the medical team confirms preparation and follow-up. Do not change medicines yourself to fit travel dates.
Share your goal, history and recent tests privately through the channel provided by the team for physician review. Include eGFR, creatinine and UACR if relevant and available. Do not post medical records in public comments.
Contact Khun KimSupplied photograph of a presenter explaining cell technology · Owner-supplied image; not verification of product identity, licensing or outcomes
No. Compare product, indication, evidence and quality, not culture status alone.
No. Dose needs clinical rationale and quality information; outcomes vary.
It depends on harvesting, preparation and administration; confirm with the medical team before booking.
5 points • reviewed 2026-11-14
Reviewed and last updated: 2026-11-14
10 sources • every claim is traceable
https://www.ehlbio.co.kr/company/about/
https://www.ehlbio.co.kr/rd/gmp/
https://www.ehlbio.co.kr/company/contact/
https://mohw.go.kr/board.es?act=view&bid=0027&list_no=1483481&mid=a10503000000
https://www.mohw.go.kr/board.es?act=view&bid=0026&list_no=1487217&mid=a10409020000
https://www.ehlbio.co.kr/company/history/
https://www.ehlbio.co.kr/rd/institute/
https://www.ehlbio.co.kr/rd/patent/
https://www.ehlbio.co.kr/conditioned/
https://www.ehlbio.co.kr/immune_cell/
Last updated: 2026-11-14 · This content is for information only and is not medical advice. Consult a qualified doctor before making treatment decisions.
Back to categories